With two medications approved for tardive dyskinesia, how do you choose between them? And how does anyone afford their $80-140,000 a year price tag? We'll walk you through the steps, and show you how to get these VMAT2 inhibitors approved by insurance. Date
Published: 1/20/2020
Duration: 23 minutes, 51 seconds
Article Referenced: "How to Treat Tardive Dyskinesia," The Carlat Psychiatry Report, January 2020
Take the Podcast Survey to help us launch a CME option in 2020.
No transcript available.
POWERED BY BLUBRRY
